{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:29Z","timestamp":1753891889099,"version":"3.41.2"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Infants with Alagille syndrome (ALGS) need to be promptly differentiated from biliary atresia (BA) at an early stage. ALGS is an autosomal, dominant, multisystem disorder with variable phenotypic penetrance caused by heterozygous mutations in JAG1 or NOTCH2, which encode the Notch signaling pathway.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We report two cases, both with cholestatic jaundice as the main manifestation, in which BA was excluded and finally diagnosed as ALGS based on characteristic facial features, serological tests, imaging, laparoscopic cholangiography, pathology and genetic findings. Both cases are novel mutant genes on chromosome 20 that have not been reported in the literature. The mutation in patient 1 was a novel heterozygous nonsense mutation (NM_000214 exon20, c.2419G\u2009&amp;gt;\u2009T, <jats:italic>p<\/jats:italic>.E807Ter), which was a spontaneous mutation. Followed up to 1 year and 6 months, the symptoms resolved with ursodeoxycholic acid and cholestyramine, and the jaundice has now subsided. Patient 2 was a novel heterozygous frameshift mutation (NM_000214 exon19, c.2367\u20132368dupTC, <jats:italic>p<\/jats:italic>.P790Lfs*31), which was inherited from his mother. This patient was followed up to 9 months and is currently awaiting liver transplantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Both cholestatic infants reported combined to exclude BA, avoid Kasai portoenterostomy (KPE), and definitively diagnose ALGS. Broadening the spectrum of JAG1 gene mutations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.1017647","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T08:18:50Z","timestamp":1666253930000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: Novel JAG1 gene mutations in two infants with alagille syndrome characterized by cholestasis"],"prefix":"10.3389","volume":"10","author":[{"given":"Yijiang","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baohai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengming","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfa","family":"Tou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/jcm11040999","article-title":"Biliary atresia in 2021: epidemiology, screening and public policy","volume":"11","author":"Schreiber","year":"2022","journal-title":"J Clin Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s12072-022-10322-x","article-title":"Dynamic analysis of Serum mmp-7 and its relationship with disease progression in biliary atresia: a multicenter prospective study","volume":"16","author":"Chi","year":"2022","journal-title":"Hepatol Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0022-3476(75)80706-2","article-title":"Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur","volume":"86","author":"Alagille","year":"1975","journal-title":"J Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"704586","DOI":"10.3389\/fphar.2021.704586","article-title":"Therapeutics development for alagille syndrome","volume":"12","author":"Sanchez","year":"2021","journal-title":"Front Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/humu.23879","article-title":"Alagille syndrome mutation update: comprehensive overview of Jag1 and Notch2 mutation frequencies and insight into missense variant classification","volume":"40","author":"Gilbert","year":"2019","journal-title":"Hum Mutat"},{"key":"B6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/diagnostics10110907","article-title":"Alagille syndrome: diagnostic challenges and advances in management","volume":"10","author":"Ayoub","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2147\/JMDH.S295441","article-title":"Multidisciplinary management of alagille syndrome","volume":"15","author":"Menon","year":"2022","journal-title":"J Multidiscip Healthc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/diagnostics11060983","article-title":"Two novel mutations in the jag1 gene in pediatric patients with alagille syndrome: the first case series in Czech Republic","volume":"11","author":"Prochazkova","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"912154","DOI":"10.3389\/fped.2022.912154","article-title":"Genetic factors and their role in the pathogenesis of biliary atresia","volume":"10","author":"Wu","year":"2022","journal-title":"Front Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e13579","DOI":"10.1111\/petr.13579","article-title":"Living donor liver transplantation in alagille syndrome-single center experience from South Asia","volume":"23","author":"Valamparampil","year":"2019","journal-title":"Pediatr Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.3390\/ijms20246247","article-title":"Novel Jag1 deletion variant in patient with atypical alagille syndrome","volume":"20","author":"Micaglio","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1055\/s-0041-1730951","article-title":"Alagille syndrome: a focused review on clinical features, genetics, and treatment","volume":"41","author":"Kohut","year":"2021","journal-title":"Semin Liver Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41436-020-00989-8","article-title":"Genome sequencing increases diagnostic yield in clinically diagnosed alagille syndrome patients with previously negative test results","volume":"23","author":"Rajagopalan","year":"2021","journal-title":"Genet Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/hep4.1468","article-title":"Outcomes of childhood cholestasis in alagille syndrome: results of a multicenter observational study","volume":"4","author":"Kamath","year":"2020","journal-title":"Hepatol Commun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40265-021-01649-0","article-title":"Maralixibat: first approval","volume":"82","author":"Shirley","year":"2022","journal-title":"Drugs"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s40265-021-01594-y","article-title":"Odevixibat: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1017647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T08:18:53Z","timestamp":1666253933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1017647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":17,"alternative-id":["10.3389\/fped.2022.1017647"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1017647","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"article-number":"1017647"}}